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Abstract
Background: To determine the major predictive factors for fetal acidemia in placental abruption.
Methods: A retrospective review of pregnancies with placental abruption was performed using a logistic regression
model. Fetal acidemia was defined as a pH of less than 7.0 in umbilical artery. The severe abruption score, which
was derived from a linear discriminant function, was calculated to determine the probability of fetal acidemia.
Results: Fetal acidemia was seen in 43 survivors (43/222, 19%). A logistic regression model showed bradycardia (OR
(odds ratio) 50.34, 95% CI 11.07 – 228.93), and late decelerations (OR 15.13, 3.05 – 74.97), but not abnormal
ultrasonographic findings were to be associated with the occurrence of fetal acidemia. The severe abruption score
was calculated for the occurrence of fetal acidemia, using 6 items including vaginal bleeding, gestational age,
abdominal pain, abnormal ultrasonographic finding, late decelerations, and bradycardia.
Conclusions: An abnormal FHR pattern, especially bradycardia is the most significant risk factor in placental
abruption predicting fetal acidemia, regardless of the presence of abnormal ultrasonographic findings or gestational
age.
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Background
Placental abruption is one of the serious complications
of late pregnancy, because it leads to both poor maternal
and fetal/neonatal outcome [1]. The diagnosis of placen-
tal abruption usually depends on the clinical manifesta-
tions, and confirmed the placental detachment after
delivery [2,3]. The usefulnesses of ultrasonography [4,5]
and fetal heart rate (FHR) monitoring have been
reported as the adjunctive diagnosis, and they are both
widely used for this purpose. But controversy exists as to
whether ultrasonographic findings are useful in deter-
mining the diagnosis, management and the relation to
fetal outcome. On the other hand, abnormal FHR pat-
terns are also common in severe cases [6], reflecting
uteroplacental insufficiency resulting from interruption
of placental blood flow [7]. However; few studies have
compared the simultaneous use of these two modalities
in cases of placental abruption.
Pathological acidemia is defined as a pH of less than
7.0 and it is an objective measure of intrapartum
hypoxia-ischemia and has been correlated with the oc-
currence of hypoxic ischemic encephalopathy (HIE) [8].
It has been reported that placental abruption is as a reli-
able factor for fetal acidemia as well as FHR abnormality
in both preterm and term infants [9,10], although the
rate of the occurrence of fetal acidemia has not been
well described in placental abruption.
The purpose of this study was therefore to determine
the important factors and to establish the predictive
score for acidemia in placental abruption, by evaluating
clinical assessments as well as adjunctive laboratory tests
such as ultrasonographic findings and FHR patterns.
Methods
The approval of the institutional review board (Tokyo
Women’s Medical University) was obtained before the
start of this retrospective, case–control study. All single-
ton births, born between 24 and 40 weeks of gestation
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between January, 1st, 2009, and December 31st, 2009
were included. The medical records of mothers and neo-
nates in the 94 institutes where these infants were born,
comprising the Perinatal Research Network in Japan
(PRNJ) listed in the ‘Acknowledgements’ were reviewed.
Gestational age was determined based on the mother’s
last menstrual period and first and second trimester ob-
stetric ultrasonography. More than 30 variables were
assessed, including pregestational and perinatal factors.
Preeclampsia/superimposed preeclampsia was diag-
nosed according to the criteria of National High Blood
Pressure Education Program Working Group on High
Blood Pressure in Pregnancy [11]. Details of the diagno-
sis, onset place, time from onset of symptoms to admis-
sion/delivery, and clinical management of any relevant
condition were recorded.
The diagnosis of placental abruption was based pri-
marily on the one or more of the following clinical man-
ifestations: vaginal bleeding, abdominal pain, uterine
tenderness, with/without an abnormal FHR tracing [2],
and confirmed the placental detachment after delivery.
The presence of hematoma during a cesarean section or
coagulation/massive genital bleeding during vaginal de-
livery was considered to indicate placental detachment.
Women found to have a healthy placenta, and those
with chronic abruption, were excluded from this study.
Chronic abruption-oligohydramnios sequence (CAOS)
was defined by the following criteria: (1) clinically sig-
nificant vaginal bleeding in the absence of placenta
previa or other identifiable source of bleeding, (2) amni-
otic fluid volume initially documented as normal and (3)
oligohydramnios (amniotic fluid index < or = 5) eventu-
ally developing without concurrent evidence of ruptured
membranes [12].
Ultrasonographic findings were reported as follows;
preplacental collection under the chorionic plate, in-
creased heterogenous placental thickness (more than
5 cm), retroplacental collection, marginal hematoma,
subchorionic hematoma, or intra-amniotic hematoma [5].
FHR patterns were defined as abnormal when one of the
following patterns was detected: persistent late decelera-
tions, severe atypical deceleration, prolonged deceleration,
or bradycardia [13]. The same patterns were also used for
the assessment of preterm fetuses. A baseline FHR of less
than 100 bpm was noted as bradycardia (>3 mins) [13].
This includes FHR detected only by hand-held Doppler
fetal heart detectors or auscultation in some cases.
The live fetuses were delivered by cesarean section be-
cause of abnormal FHR patterns or maternal indications,
such as massive genital bleeding. At delivery, the umbil-
ical cord was double clamped. 0.2 ml of arterial blood
was collected on ice for blood gas analysis. An abnormal
umbilical arterial pH (fetal acidemia) was defined as a
value of less than 7.0 [14].
An adverse outcome for the neonate was defined as
the occurrence of death before hospital discharge or a
diagnosis of cerebral palsy. The outcome of pregnancy
was classified as poor (cases) and good (controls), with a
poor outcome defined as a fetal arterial cord blood pH
of less than 7.0, irrespective of neonatal outcome. The
results were expressed as mean ± standard deviation
(SD), medians with range, or numbers with the percent-
age. Statistical analyses were performed with the Statflez
6.0 software package (Archtech Co., Ltd., Osaka, Japan.
URL:http://www.statflex.Net/) and were carried out
using the chi-square test, Fisher’s exact probability test,
and the Mann–Whitney U test. p values of less than
0.05 were considered to be significant. The odds ratio
(OR) and 95% confidence intervals (CI) were calculated
to estimate the relative risk between cases and controls
with regard to risk factors for fetal acidemia. They
were compared in both univariate and multivariate ana-
lyses. Logistic regression models were used to assess
confounding effects and to construct a discriminant
function. Receiver operating characteristic (ROC) curves
were constructed to evaluate the relationship between
the sensitivity and false positive rate (1-specificity) for
the indicators of fetal acidemia. The optimal cut-off
point was determined to be the point corresponding
to the highest sensitivity in relation to the highest
specificity.
Results
There were 355 patients complicated by placental abrup-
tion. The overall number of deliveries in 94 institutes
was 54,628 and the rate of placental abruption was
0.65%. Eighty-nine fetuses were dead on admission
(intrauterine fetal death), while the remaining 266 fe-
tuses were alive. The latter cases were included in the
analysis for this study. Although eighty three cases were
not recorded mainly due to the emergency nature of the
situation without CTG recordings, rapid frequent con-
tractions with no resting tone were observed in 72 out
of the remaining 183 cases. The mean gestational age at
delivery was 34.1 ± 3.4 weeks (preterm: 200 patients,
term: 66 patients). In spite of resuscitation, an Apgar
score of 0 at five minutes was seen in 7 cases, which
resulted in adverse outcome.
Abnormal ultrasonographic findings were observed in
183 patients (68.8%), mainly indicating retroplacental
anechoicity (121 cases), and increased placental thick-
ness (117 cases).
Abnormal FHR patterns were observed in 166 patients
(62.4%). The main abnormal FHR results were as
follows: persistent late decelerations, 51 cases and
prolonged deceleration, 86 (including by auscultation)
cases. Cesarean section was performed in 256 patients
(96.2%). Of these patients, a neonatal adverse outcome
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was seen in 18 cases. On the other hand, in the
remaining 10 patients who delivered vaginally, a neo-
natal adverse outcome was not observed.
As the data regarding the umbilical artery pH in 44
cases were not obtained, we used the data from the
remaining 222 cases, and fetal acidemia was seen in 43
(19%). These patients were divided into two groups:
poor outcome group (case, n = 43), and good outcome
group (control, n = 179). Neonatal adverse outcome
cases included 22 patients and there was a significant
difference between cases and controls in the occurrence
of neonatal adverse outcome (14/ 43, 32.6% vs. 8/179,
4.5%, p < 0.001).
The clinical demographics of the cases are given in
Table 1. Risk factors for cases and controls based on the
occurrence of perinatal events in placental abruption
were analyzed. In the univariate analysis, abnormal FHR
patterns, bradycardia, and maternal unstable condition
necessitating the blood transfusion were more frequent
in cases.
Factors affecting umbilical arterial pH were deter-
mined by multiple regression analysis (Table 2). As a re-
sult, four factors significantly affected umbilical arterial
pH; partial regression coefficients of bradycardia, persist-
ent late decelerations, abnormal ultrasonographic find-
ings, and abdominal pain were −0.256, -0.133, -0.054,
and −0.047, respectively.
Using a logistic regression model, bradycardia (OR
(odds ratio) 50.34, 95%CI 11.07 – 228.93), and persistent
late decelerations (OR 15.13, 3.05 – 74.97), but not
abnormal ultrasonographic findings were to be associ-
ated with the occurrence of fetal acidemia (Table 3).
The statistically significant factors identified by the
multiple logistic regression analysis were subjected to
stepwise regression analysis to construct a linear dis-
criminant function: A + 2B + 2C + 2D + 7E + 10 F, where
A was vaginal bleeding (0, no; 1, yes), B was gestational
age less than 35 weeks (0, no; 1, yes), C was abdominal
pain (0, no; 1, yes), D was abnormal ultrasonographic
finding (0, no; 1, yes), E was persistent late decelerations
(0, no; 1, yes), and F was bradycardia (0, no; 1, yes). This
discriminant function was named as ‘severe abruption
score’ (SAS). A ROC curve is shown in Figure 1a. The
area under the curve (AUC) was 0.855. The sensitivity
and specificity curve showed that the optimal cut-off
value for the SAS was 11 [sensitivity: 83.7%; specificity:
78.2%; positive predictive value (PPV): 43.6%; negative
predictive value (NPV): 93.8%] to 12 [sensitivity: 69.8%;
specificity: 81%; positive predictive value (PPV): 48%;
negative predictive value (NPV): 95.2%], as shown in
Figure 1b. Then, logistic regression analysis was
performed to make clear the relationship between the
SAS and the probability of fetal acidemia in Figure 2.
When this score was 15, the probability of fetal acidemia
was 0.5.
Discussion
We have evaluated clinical symptoms, ultrasonographic
findings and FHR patterns in placental abruption from
the analysis of relatively large number of cases and
Table 1 Results of univariate analysis in terms of risk factors of fetal acidemia
Case (N = 43) Control (N = 179) p
Primipara 24 (55.8%) 75 (41.9%) 0.14
Maternal transfer 28 (65.1%) 109 (60.9) 0.742
Preeclampsia/eclampsia or chronic hypertension 16 (37.2%) 42 (23.5%) 0.104
Vaginal bleeding 21 (48.8%) 98 (54.8%) 0.596
Abdominal pain 20 (46.5%) 57 (31.8%) 0.104
Abnormal ultrasonographic finding 35 (81.4%) 128 (71.5%) 0.257
Abnormal FHR patterns 42 (97.7%) 98 (54.7%) <0.0001
Bradycardia 32 (74.4%) 42 (23.5%) <0.0001
Persistent late decelerations 9(20.9%) 34 (19.0%) 0.919
Cesarean section 41 (95.3%) 171 (95.5%) 0.993
Gestational age at delivery (weeks) 34(24–39)* 35 (24–41)* 0.07
Gestational age at delivery <35 wks 19 (44.2%) 99 (55.3%) 0.253
Birth weight (g) 1997 (517–3504)* 2062 (774–3450)* 0.107
Male 22 (51.2%) 108 (60.3%) 0.568
Apgar score (1 min) 2(0–6)* 6 (0–9)* <0.0001
Apgar score (5 min) 5 (0–9)* 8 (0–10)* <0.0001
Blood transfusion 21 (48.8%) 37 (20.7%) 0.006
*represents median (min-max).
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showed that ‘severe abruption score’ is useful for predic-
tion for fetal acidemia in placental abruption, although
this score is derived from the retrospective diagnosis of
abruption and cannot be used before delivery.
Because the etiology of placental abruption is hetero-
geneous and speculative, and clinical abruption is the
final culmination of a long-standing disease process
within the placenta, [15] the diagnosis of placental
abruption in this study was based on the clinical mani-
festations, and the placental detachment was confirmed
after delivery. Therefore, the clinical background of pa-
tients in the present study may be more severe than
some other studies [3,16]. As a result, the percentage of
maternal and fetal/neonatal morbidity and mortality
was high.
The association between placental abruption and the
occurrence of infant neurodevelopmental disorders has
been confirmed [17]. Abruption increases hypoxic in-
sults through two mechanisms [7]. The separation of the
placenta from the maternal blood supply, depending on
the extent, decreases the placental surface area and thus
oxygen exchange. In addition, there is often a marked in-
crease in the frequency, and occasionally, duration of
contractions, which prolongs the interval during which
oxygen delivery to the intervillous space is interrupted.
Since placental abruption is mechanism of fetal hypoxia/
acidosis, placental abruption is one of the most import-
ant factors for fetal acidemia [9,10]. In severe cases, the
characteristic FHR patterns will be persistent late decel-
erations, prolonged deceleration, and bradycardia may
occur. In the present study, we have defined pathological
acidemia as an umbilical arterial pH less than 7.0, which
has been linked to the occurrence of HIE [8], and have
shown that bradycardia is the major risk factor in pla-
cental abruption predicting fetal acidemia, regardless of
the presence of abnormal ultrasonographic findings or
gestational age.
On the other hand, a severe abruption score derived
by discriminant function was calculated for the probabil-
ity of fetal acidemia as mentioned above. As shown in
Figure 1b, optimal cut-off value for severe abruption
score was estimated to be 11–12. Even if fetal acidemia
was present, there is a possibility for intact survival, if
the prompt and aggressive therapy such as brain
hypothermia therapy is started as soon as possible [18].
Therefore, this score for confirmed cases might be useful
for predicting the need for neonatal intensive therapy
soon after delivery.
Moreover, this score represents not only the possibility
of prediction for fetal acidemia, but also highlights the
significance of each item, thus facilitating clinical diag-
nosis in placental abruption. The amount of vaginal
bleeding correlates poorly with the degree of placental
separation and does not serve as a useful marker of
impending fetal risk. Even small amounts of vaginal
bleeding in the setting of abdominal pain and uterine
contractions, we should make close maternal and fetal
evaluation for placental abruption [19].
As an adjunctive diagnostic method for placental
abruption, the role of ultrasonography is not large.
Glantz and colleagues, in a retrospective cohort study,
found that the sensitivity, specificity, and positive and
negative predictive values of ultrasonography for placen-
tal abruption were 24%, 96%, 88% and 53%, respectively
Table 2 Results of multiple regression analysis affecting umbilical arterial pH
Potential predictors Partial regression coefficient 95% CI p
Bradycardia −0.256 −0.302 – -0.210 <0.0001
Persistent late decelerations −0.133 −0.186 - -0.08 <0.0001
Gestational week at delivery 0.006 −0.0002 – 0.011 0.059
Abnormal ultrasonographic findings −0.054 −0.099 – -0.009 0.019
Abdominal pain −0.047 −0.089 – -0.006 0.026
Vaginal bleeding −0.021 −0.061 – 0.02 0.318
Table 3 Results of multivariate analysis in terms of risk factors for fetal acidemia
Potential predictors Odds ratio 95% CI p
Bradycardia 50.34 11.07 – 228.93 <0.0001
Persistent late decelerations 15.13 3.05 – 74.97 <0.0001
Gestational week at delivery < 35 weeks 1.82 0.81 – 4.17 0.152
Abnormal ultrasonographic findings 2.01 0.75 – 5.39 0.164
Abdominal pain 1.70 0.73 – 3.92 0.216
Vaginal bleeding 1.47 0.64 – 3.44 0.362
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and stressed that a negative ultrasonogram did not rule
out an abruption [20]. Jaffe and colleagues also found
that ultrasonography identified only 50% of abruptions
confirmed by pathology [21]. In the present study,
abnormal ultrasonographic findings were observed in
183 patients (68.8%). This frequency was slightly high
compared to other studies, which might be reflected by
the collection of more severe cases. However, using a lo-
gistic regression model, abnormal ultrasonographic find-
ing was not to be associated with the occurrence of fetal
acidemia. Nyberg and colleagues, in a retrospective
review of 69 cases of abruption, found that fetal mortal-
ity correlated with the worse prognosis occurring in
retroplacental abruption [22]. They did not analyze the
relationship between ultrasonographic findings and an
adverse outcome of the neonate including neonatal/in-
fantile death before hospital discharge or a diagnosis of
cerebral palsy.
There are several limitations in the present study.
First, this study has been done by a retrospective fash-
ion; therefore, further study is warranted to prove the
usefulness of this score prospectively. Second, as a se-
vere abruption score is based only on cases where a
diagnosis of abruption was confirmed according to pla-
cental appearance just after delivery and is designed to
be used immediately after delivery, this score should be
used with caution. Finally, it is important to understand
that this score is influenced by the sample size. The
prognosis of the babies born following placental abrup-
tion will be reported separately.
Conclusions
In conclusion, an abnormal FHR pattern, especially
bradycardia is the most significant risk factor in placen-
tal abruption predicting fetal acidemia, and is more
specificity
Se
ns
iti
vi
ty
Severe abruption score (SAS)
sensitivity
specificity
(a) (b)
Figure 1 Severe abruption score (SAS) in cases with placental abruption. (a) Receiver operating characteristics curve. (b). Sensivity and
specificity curve.
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Figure 2 Relationship between the severe abruption score
(SAS) and the probability of fetal acidemia in the cases of
placental abruption.
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valuable than ultrasound in predicting outcome in pla-
cental abruption during pregnancy.
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